Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Accumulated Expenses (2024 - 2025)

Carlsmed's Accumulated Expenses history spans 2 years, with the latest figure at $3.3 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 22.33% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $3.3 million, up 22.33%, while the annual FY2025 figure was $3.3 million, 22.33% up from the prior year.
  • Accumulated Expenses reached $3.3 million in Q4 2025 per CARL's latest filing, up from $3.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.3 million in Q4 2025 to a low of $2.7 million in Q4 2024.